BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 28, 2001
View Archived Issues
Licensing opportunity from NIH: methods of treating cancer, diabetes based on adrenomedullin
Read More
Available for licensing from the NIH: novel inhibitors of p53
Read More
InKine's Colirest enters pivotal trial for IBD
Read More
Glycogen phosphorylase inhibitor + metformin combinations effective and safe in ob/ob mice
Read More
Genistein derivative shows raloxifene-like SERM profile
Read More
Antidiabetic effects and excellent pharmacokinetics described for new PTP1B inhibitor
Read More
Novartis prepares new somatostatin analogues with improved therapeutic profile
Read More
Bone remodeling reduced by TSE-424 in prospective trial in postmenopausal women
Read More
Ciprofloxacin GR proves suitable for once-daily dosing in phase I study
Read More
GenVec and Varian Medical extend collaborative agreement for treatment of cancer
Read More
GPC Biotech delivers seven antimicrobial targets to Byk Gulden
Read More
Long-term therapy with DPP IV inhibitor may be beneficial in diabetes
Read More
Japanese regulatory agency approves Allergan's Botox for cervical dystonia
Read More
NCX-701 shows good bioavailability and safety in phase I
Read More
AstraZeneca seeks U.S. and European approval of new superstatin Crestor
Read More
FDA advisory committee to discuss NDA for Remodulin in August
Read More
Development of Viozan discontinued
Read More
SuperGen's DHEA phosphocholine demonstrates antidiabetic potential
Read More
AstraZeneca files sNDA seeking new indications for Merrem I.V.
Read More
Oral insulin formulations devised by Emisphere effective in animals, progress to the clinic
Read More
Neutralase used for first time in congenital heart procedure
Read More
Potent and selective factor Xa inhibitors useful as anticoagulants
Read More
Fujisawa's Protopic approved in Canada
Read More
A-76202 analogues inhibit alpha-glucosidase, useful for diabetes, obesity, AIDS
Read More
Boehringer Ingelheim claims new CRGP antagonists and uses thereof
Read More
Several related series of compounds identified at Merck as NMDA antagonists
Read More
Cytokinetics and GlaxoSmithKline establish cancer drug discovery alliance
Read More